Proteus Venture Partners

Proteus Venture Partners is a healthcare-focused investment and advisory firm centered on regenerative medicine rather than a drug-development operating biotech. The firm has been described as investing in cell therapies, tissue-engineered products, tools and enabling devices, regenerative compounds, and aesthetic medicine, with a global venture capital strategy. Historical reporting indicates Proteus sought to back 10 to 15 regenerative medicine companies across stages ranging from early academic spinouts to public companies with clinical programs. Publicly available information ties the firm closely to founder and managing partner Greg Bonfiglio and to the broader stem cell and cell-and-gene therapy ecosystem.